RENAL ANEMIA OF CHRONIC KIDNEY DISEASE
Clinical trials for RENAL ANEMIA OF CHRONIC KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new RENAL ANEMIA OF CHRONIC KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for RENAL ANEMIA OF CHRONIC KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for dialysis patients: Long-Acting anemia drug under study
Disease control Recruiting nowThis study tests a new long-acting drug called pegmolesatide for anemia in people with chronic kidney disease who are on dialysis. It aims to see if switching from current anemia treatments to this drug is safe and effective. About 96 adults will receive the drug for 12 weeks and…
Matched conditions: RENAL ANEMIA OF CHRONIC KIDNEY DISEASE
Phase: NA • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New combo therapy aims to boost red blood cells in dialysis patients
Disease control Recruiting nowThis study tests a new drug called pegmolesatide, alone or combined with roxadustat, to treat anemia in 240 adults on dialysis for chronic kidney disease. Participants currently on another anemia drug (rHuEPO) will switch to one of three treatment plans for 24 weeks. The goal is …
Matched conditions: RENAL ANEMIA OF CHRONIC KIDNEY DISEASE
Phase: PHASE4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 26, 2026 15:52 UTC